Denis Charles Talbot
Centre hospitalier universitaire de Québec · 290 works · 7,145 citations · h-index 44
Top works
- Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin
- Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
- A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer
- Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
- Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
- Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.
- What Oncologists Believe They Said and What Patients Believe They Heard: An Analysis of Phase I Trial Discussions
- 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
- Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.
- Phase II trial of UFT in advanced colorectal and gastric cancer
- Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases
- Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder
- Isolation of a small molecule inhibitor of DNA base excision repair
- Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
- Anatomic and Functional Imaging of Metastatic Carcinoid Tumors
- Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
- Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents
- A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study
- Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer
- Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study